Changing the Game in OA Pain: What Every Clinician Should Know About Monoclonal Antibodies

This lecture will explore the science, clinical application, and evidence behind the use of anti-nerve growth factor (NGF) monoclonal antibodies for the control of osteoarthritis pain in dogs. Attendees will gain an understanding of the mechanism of action, safety profile, and therapeutic benefits of this targeted approach to pain management. Emphasis will be placed on patient selection, real-world outcomes, and integrating monoclonal antibodies into multimodal OA treatment plans.